Recombinant lactococcal-based oral vaccine for protection against Streptococcus agalactiae infections in tilapia (Oreochromis niloticus)

被引:4
作者
Wong, Kuan Yee [1 ]
Khair, Megat Hamzah Megat Mazhar [2 ]
Song, Adelene Ai Lian [2 ,6 ]
Masarudin, Mas Jaffri [3 ,7 ]
Loh, Jiun Yan [4 ]
Chong, Chou Min [5 ]
Beardall, John [8 ]
Teo, Michelle Yee Mun [1 ]
In, Lionel Lian Aun [1 ]
机构
[1] UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia
[2] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Serdang, Selangor, Malaysia
[3] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia
[4] James Cook Univ, Trop Futures Inst TFI, 149 Sims Dr, Singapore 387380, Singapore
[5] Univ Putra Malaysia, Int Inst Aquaculture & Aquat Sci I AQUAS, Lab Sustainable Aquaculture AquaLab, Port Dickson, Negeri Sembilan, Malaysia
[6] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia
[7] Univ Putra Malaysia, Inst Nanosci & Nanotechnol, Nanomat Synth & Characterisat Lab, Serdang, Selangor, Malaysia
[8] Monash Univ, Sch Biol Sci, Clayton, Australia
关键词
Streptococcus agalactiae; Lactococcus lactis; Orally administered vaccine; Tilapia; Surface immunogenic protein; Antibiotic resistance; GROUP-B STREPTOCOCCUS; HYDROPHILA;
D O I
10.1016/j.fsi.2024.109572
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
Streptococcosis outbreaks caused by Streptococcus agalactiae infection in tilapia aquaculture have been consistently reported and associated with high mortality and morbidity leading to significant economic losses. Existing vaccine candidates against Streptococcus spp. are designed for intraperitoneal injections that are not practical and labor-intensive which have prompted farmers to protect aquatic animals with antibiotics, thus encouraging the emergence of multidrug resistant bacteria. In this study, a live recombinant L. lactis vaccine expressing a 1403 bp surface immunogenic protein (SIP) and a 1100 bp truncated SIP (tSIP) gene was developed and evaluated against S. agalactiae infection in tilapia. Both SIP and tSIP sequences were cloned and transformed into L. lactis. The recombinant L. lactis vaccine was orally administered to juvenile tilapia for a month. Detection of SIP-specific serum IgM in vaccinated groups compared to control groups indicated that recombinant proteins expressed from L. lactis could elicit immunogenic reactions in tilapia. Fish immunized with the tSIP vaccine also showed the highest level of protection compared to other test groups, and the mortality rate was significantly reduced compared to both control groups. The relative percentage of survival (RPS) against S. agalactiae for both SIP and tSIP-vaccinated groups was 50 % and 89 %, respectively, at 14 days post-challenge. Significant up-regulation of IgM, IL-1 beta, IL-10, TNF-alpha and IFN-gamma were observed at day 34 between the vaccinated and control groups. These results indicated that the recombinant lactococcal tSIP vaccine can elicit both cell-mediated and humoral responses and is recommended as a potential oral vaccine against S. agalactiae infection. Future work will include further in vivo challenge assessments of this vaccine candidate fused with adjuvants to boost immunogenicity levels in tilapia.
引用
收藏
页数:9
相关论文
共 55 条
[1]  
Amal M. N. A., 2011, Pertanika Journal of Tropical Agricultural Science, V34, P195
[2]   Live recombinant Lactococcus lactis vaccine expressing aerolysin genes D1 and D4 for protection against Aeromonas hydrophila in tilapia (Oreochromis niloticus) [J].
Anuradha, K. ;
Foo, H. L. ;
Mariana, N. S. ;
Loh, T. C. ;
Yusoff, K. ;
Hassan, M. D. ;
Sasan, H. ;
Raha, A. R. .
JOURNAL OF APPLIED MICROBIOLOGY, 2010, 109 (05) :1632-1642
[3]   Immune Response of Tilapia⁢ (Oreochromis niloticus)⁢ after Vaccination with Autoclave-killed, Heat-killed, and Formalin-killed Whole Cell ⁢Aeromonas hydrophila ⁢Vaccines as Possible Serotype-independent Vaccines [J].
Bactol, Ivan Daryl C. ;
Padilla, Larry, V ;
Hilario, Allan L. .
INTERNATIONAL JOURNAL OF AGRICULTURE AND BIOLOGY, 2018, 20 (04) :846-850
[4]   Persistence of a single clone of Streptococcus agalactiae causing disease in tilapia (Oreochromis sp.) cultured in Colombia over 8 years [J].
Barato, P. ;
Martins, E. R. ;
Melo-Cristino, J. ;
Iregui, C. A. ;
Ramirez, M. .
JOURNAL OF FISH DISEASES, 2015, 38 (12) :1083-1087
[5]   Oral immunization with surface immunogenic protein from Streptococcus agalactiae expressed in Lactococcus lactis induces protective immune responses of tilapia (Oreochromis niloticus) [J].
Cai, Yu-zhen ;
Liu, Zhi-gang ;
Lu, Mai-xin ;
Ke, Xiao-li ;
Zhang, De-feng ;
Gao, Feng-ying ;
Cao, Jian-meng ;
Wang, Miao ;
Yi, Meng-meng .
AQUACULTURE REPORTS, 2020, 18
[6]   Immune response and protective efficacy of mannosylated polyethylenimine (PEI) as an antigen delivery vector, administered with a Streptococcus agalactiae DNA vaccine in Nile tilapia (Oreochromis niloticus) [J].
Chen, Xin-Jin ;
Wangkahart, Eakapol ;
Cai, Jia ;
Huang, Yu ;
Jian, Ji-chang ;
Wang, Bei .
FISH & SHELLFISH IMMUNOLOGY, 2023, 135
[7]   Advances in Aquaculture Vaccines Against Fish Pathogens: Global Status and Current Trends [J].
Dadar, Maryam ;
Dhama, Kuldeep ;
Vakharia, Vikram N. ;
Hoseinifar, Seyed Hossein ;
Karthik, Kumaragurubaran ;
Tiwari, Ruchi ;
Khandia, Rekha ;
Munjal, Ashok ;
Salgado-Miranda, Celene ;
Joshi, Sunil K. .
REVIEWS IN FISHERIES SCIENCE & AQUACULTURE, 2017, 25 (03) :184-217
[8]  
Dang M., 2021, Vaccines, V9, P1
[9]  
Diaz-Dinamarca D.A., 2020, Vaccines, V8
[10]  
Dullah H., 2020, Sustainability, V12, P1